TACSTD2 and familial pancreatic carcinoma: It has been documented that TROP2 is highly expressed in a wide range of solid tumors, including breast, lung, ovarian, gastric, colorectal, and pancreatic cancers, but is barely expressed in normal tissues [9, 11, 12, 18].